News
Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an...
Clinical Trials
Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine
Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance...
News
COVID-19 vaccine : Bharat Biotech to provide 55 lakh Covaxin doses at Rs 295 per dose
Bharat Biotech inked a purchase agreement with the Government of India on January 11 to provide 55 lakh doses of COVID-19 vaccine Covaxin at...
News
Covid Vaccine: India Orders Over 6 Crore Doses From SII, Bharat Biotech
The government has placed orders in advanced commitments for over 6 crore doses of Covid-19 vaccine from Serum Institute of India (SII) and Bharat...
News
European Commission approves Roche’s Xofluza to treat influenza
Roche announced that the EC has approved Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 years and above. In...
Drug Research
Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Baxter International Inc., a global leader in sterile medication production and delivery, announced that Baxter BioPharma Solutions has entered into an agreement to provide...
News
Dr. Reddy’s Laboratories announces the launch of Febuxostat Tablets in the U.S. Market
Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) announced the launch of Febuxostat Tablets, a therapeutic equivalent generic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read